Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
gallium-68 chloride
- Development stage
- Unknown
- Lead developer
- Oryx Isotopes
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
Gallium-68 chloride is a positron-emitting radiopharmaceutical precursor and diagnostic PET imaging agent. Produced via a Germanium-68/Gallium-68 generator, it exists as a solution of the radioisotope gallium-68 in chloride form. While it is primarily utilized as a starting material for the radiolabeling of various tumor-targeting ligands (such as DOTATATE or PSMA), it can also be used directly as a tracer for imaging. In the context of Oryx Isotopes, it is positioned as an approved product for general tumor imaging. Gallium-68 decays by positron emission, allowing for high-resolution Positron Emission Tomography (PET) imaging to visualize physiological or pathological processes. When used as a standalone tracer, its localization can be influenced by biological processes such as iron metabolism due to the chemical similarity between Ga3+ and Fe3+ ions.
- Other names
- Gallium-68 ChlorideGallium68 ChlorideGallium 68 Chloride68Ga-chlorideGallium (68Ga) chloride
Beyond the preview
Go deeper on gallium-68 chloride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on gallium-68 chloride.